Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Clinical trial NCT01812668 · COMPLETED

Trial details

NCT number: NCT01812668
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2013-03-01
Primary completion: 2019-01-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.